Jeonjinbio Co. Ltd
Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 200… Read more
Jeonjinbio Co. Ltd (110020) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.018x
Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has a cash flow conversion efficiency ratio of 0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩313.21 Million) by net assets (₩17.72 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jeonjinbio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Jeonjinbio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jeonjinbio Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jeonjinbio Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SaintMed Public Company Limited
BK:SMD
|
0.073x |
|
Sun Peak Metals Corp
OTCQB:SUNPF
|
-0.055x |
|
Signal Advance Inc
PINK:SIGL
|
0.023x |
|
Chuang's China Investments Limited
F:CUG
|
0.046x |
|
Enwell Energy plc
PINK:RGPMF
|
0.008x |
|
Seni Jaya Corporation Bhd
KLSE:9431
|
0.050x |
|
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG
|
-31.776x |
|
HOLALUZ-CLIDOM SA EO 003
F:4H2
|
N/A |
Annual Cash Flow Conversion Efficiency for Jeonjinbio Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩17.66 Billion | ₩3.01 Billion | 0.170x | +452.06% |
| 2023-12-31 | ₩6.22 Billion | ₩-300.60 Million | -0.048x | +87.61% |
| 2022-12-31 | ₩9.51 Billion | ₩-3.71 Billion | -0.390x | -76.65% |
| 2021-12-31 | ₩10.80 Billion | ₩-2.38 Billion | -0.221x | -7.88% |
| 2020-12-31 | ₩11.28 Billion | ₩-2.31 Billion | -0.205x | +54.32% |
| 2019-12-31 | ₩2.90 Billion | ₩-1.30 Billion | -0.448x | +18.90% |
| 2018-12-31 | ₩3.91 Billion | ₩-2.16 Billion | -0.553x | +69.24% |
| 2017-12-31 | ₩229.96 Million | ₩-413.19 Million | -1.797x | -2154.30% |
| 2016-12-31 | ₩2.28 Billion | ₩-181.90 Million | -0.080x | +94.83% |
| 2015-12-31 | ₩1.27 Billion | ₩-1.95 Billion | -1.541x | -- |